AstraZeneca rebounds after Monday39;s fall
Miners down as metal prices fall on strong dollar, China worries
FTSE 100 up 0.1, FTSE 250 off 0.5

June 20 Reuters UK39;s benchmark FTSE 100 index edged up on Tuesday, reversing early losses, as rising healthcare stocks outweighed declines in miners, with investors keenly awaiting key economic data and the Bank of England39;s rate decision later this week.

The resourceheavy FTSE 100 rose 0.1 at 0828 GMT, after dropping as much as 0.3 and hitting a oneweek low in early trading. The FTSE 250 midcap index fell 0.5.

AstraZeneca rebounded 1 after Monday39;s drop following a report on the company39;s plans to spin off its China business, while GSK gained 0.7, boosting the healthcare sector.

Their European peer Sanofi jumped 2.4 after it said it prevailed in Zantac arbitration initiated by Boehringer Ingelheim BI.

Meanwhile, metals prices dipped as China39;s benchmark rate cuts failed to soothe investor concerns around the top consumer39;s economic growth, dragging mining stocks 1 lower.

Investors overviewed it China39;s rate cuts as it39;s somehow insufficient to help bed in the economic recovery that was expected earlier which is always something of a challenge, said Richard Flax, chief investment officer at Moneyfarm.

Investors, however, will be widely vigilant of domestic inflation data due Wednesday, to assess the state of economy, leading up to the BoE39;s policy decision on Thursday, with traders expecting another…